SARS-COV2 clinical trials
Also written SARS-CoV-2.
How each study uses SARS-COV2 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the SARS-COV2 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 4
Institut de Formation et de Recherche en Médecine de Montagne (1) · AIM Vaccine Co., Ltd. (1) · University of Virginia (1) · Stemirna Therapeutics (1) · University Hospital, Bordeaux (1) · University of Oxford (1)
Often tested with
Tested in the same studies.
SWIM816 (1)
Studies
Open first, then newest update. How each study uses SARS-COV2 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Virus and Bronchial Epithelium in Children and the ElderlyRecruitingNot applicableUniversity Hospital, BordeauxNCT06224062Written as SARS-CoV-2
- A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2Not yet recruitingPhase 2/3Stemirna TherapeuticsNCT05911087Written as Phase II:SWIM816;SARS-Cov-2;
- Coronaltitude - Multicentric Evaluation of the Impact on Hypoxia Sensitivity of Patients With COVID-19CompletedNot applicableInstitut de Formation et de Recherche en Médecine de MontagneNCT05167357Written as COVID19
- Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese PeopleCompletedPhase 2AIM Vaccine Co., Ltd.NCT05352867Written as SARS-CoV-2 (LVRNA009) 50μg group
- COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection StudyStatus unknownPhase 1University of OxfordNCT04864548Written as SARS-CoV-2 virus
- Convalescent Plasma for Treatment of COVID-19 Patients With PneumoniaCompletedPhase 2University of VirginiaNCT04374565Written as High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma